Evaluation of the Binding between Potential Anti-HIV DNA-Based Drugs and Viral Envelope Glycoprotein gp120 by Capillary Electrophoresis with Laser-Induced Fluorescence Detection

By Zhou W.   Tomer K.B.   Khaledi M.G.  

Analytical Biochemistry, Vol. 284, Iss. 2, 2000-09 ,pp. : 334-341

Elsevier

Access to resources Recommend Favorite

Human Erythrocyte Glycolipids Promote HIV-1 Envelope Glycoprotein-Mediated Fusion of CD4+ Cells

By Puri A.   Hug P.   Munoz-Barroso I.   Blumenthal R.  

Biochemical and Biophysical Research Communications, Vol. 242, Iss. 1, 1998-01 ,pp. : 219-225

Elsevier

Access to resources Recommend Favorite

Heparin and its derivatives bind to HIV‐1 recombinant envelope glycoproteins, rather than to recombinant HIV‐1 receptor, CD4

By Harrop Hilary A.   Rider Christopher C.  

Glycobiology, Vol. 8, Iss. 2, 1998-02 ,pp. : 131-137

Oxford University Press

Access to resources Recommend Favorite

Requirement of Cell-Cell Contact in the Induction of Jurkat T Cell Apoptosis: The Membrane-Anchored but Not Soluble Form of FasL Can Trigger Anti-CD3-Induced Apoptosis in Jurkat T Cells

By Oyaizu N.   Kayagaki N.   Yagita H.   Pahwa S.   Ikawa Y.  

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 2, 1997-09 ,pp. : 670-675

Elsevier

Access to resources Recommend Favorite

Expression of HIV-1 Envelope Glycoprotein Alters Cellular Calmodulin

By Radding W.   Pan Z.G.Q.   Hunter E.   Johnston P.   Williams J.P.   McDonald J.M.  

Biochemical and Biophysical Research Communications, Vol. 218, Iss. 1, 1996-01 ,pp. : 192-197

Elsevier

Access to resources Recommend Favorite